Cancer Vaccines: Technologies and Global Markets

  • ID: 3961025
  • Report
  • Region: Global
  • 183 Pages
  • BCC Research
15 % OFF
until Dec 31st 2018
1 of 6
The Global Market for Cancer Vaccines is Expected to Decline from Nearly $3.5 Billion in 2016 to $3.4 Billion in 2021 at a CAGR of -0.4%

FEATURED COMPANIES

  • Aduro Biotech Inc.
  • Antigen Express Inc.
  • Dendreon Corp.
  • Glaxosmithkline
  • Inovio Pharmaceuticals
  • Oncovir Inc.
  • MORE

The global market for cancer vaccines was valued at nearly $4.2 billion and $4.0 billion in 2014 and 2015, respectively. This market is expected to decline from nearly $3.5 billion in 2016 to $3.4 billion in 2021 at a compound annual growth rate (CAGR) of -0.4% for 2016-2021.

This report provides:

  • An overview of the global markets and technologies for cancer vaccines.
  • Analyses of global market trends, with data from 2014 and 2015, estimates for 2016, and projections of CAGRs through 2021.
  • Coverage of the cancer vaccines arena including diverse therapeutic platform technologies, immune-stimulating agents and approved vaccines for cancer.
  • Examination of the governmental and regulatory environment and how its effecting the market.
  • Information on new developments including products in Phase I-IV clinical trials, as well as new technologies.
  • Analysis of the market's dynamics, specifically growth and restriction factors, acquisitions and collaborations, and a look at the cancer vaccine market's current achievements and future challenges.
  • Relevant patent analysis, presented by year and by vaccine type.
  • Profiles of major players in the industry.

The scope of this study entails the global market of cancer vaccines. The report covers the total market of cancer vaccines, which includes two main areas of applications, prophylactic vaccines and therapeutic vaccines. Human papillomavirus (HPV) vaccines and hepatitis B vaccines that indirectly act against cancer are also included in the report.

The report also covers the global market of cancer vaccines by application in various cancer types such as prostate, liver, cervical and others such as lung and urinary bladder. It is discussed from both a commercial perspective and that of a research and development (R&D) perspective.

Each market is analyzed and its application, regulatory environment, new products and advancements, market projections and market shares. Sales data for the global and regional markets were corroborated for the present and forecasted values via statistical analysis and geographically sales are broken down into North America, Europe and emerging markets. The emerging market covers countries such as India, China, Japan, Korea, Taiwan, Africa, Australia, New Zealand, and Canada among others.

Analysis of patents, clinical trials, innovations and opportunities the latest trends in the cancer vaccine market and comprehensive profiles of companies that lead the cancer vaccine industry are also discussed.

Contributions Of The Study And Intended Audience

This study contributes to the areas of market growth for cancer vaccine manufacturers and users. Genomic research centers, academic institutions, government and private laboratories, as well as pharmaceutical, diagnostic and biotechnology companies, and physicians will find this study to be of interest.

READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Aduro Biotech Inc.
  • Antigen Express Inc.
  • Dendreon Corp.
  • Glaxosmithkline
  • Inovio Pharmaceuticals
  • Oncovir Inc.
  • MORE

1: Introduction

  • Study Objectives
  • Reasons For Doing This Study
  • Contributions Of The Study And Intended Audience
  • Scope Of The Study
  • Methodology
  • Information Sources

2: Executive Summary

  • Table Summary : Global Market For Cancer Vaccines By Region, Through 2021
  • Figure Summary : Global Market For Cancer Vaccines By Region, 2014-2021

3: Overview

  • Definitions
  • History Of Cancer And Its Management
  • Causes Of Cancer
  • Types Of Cancer-Causing Genes
  • Immune System And Cancer
  • Classification Of Cancer
  • Cancer Prevention
  • Types Of Cancer Treatment
  • Cancer Vaccines

4: Regulatory Aspects

  • Regulatory History Of Approved Cancer Vaccines
  • Recalls
  • Orphan Drug Designation
  • Fast Track Designations

5: New Developments

  • Prostate Cancer
  • Breast Cancer
  • Cervical Cancer
  • Liver Cancer
  • Lung Cancer
  • Stomach Cancer
  • Colorectal Cancer
  • Esophageal Cancer

6: Market Analysis

  • Market By Type
  • Market By Region

7: Industry Structure

  • Prophylactic Cancer Vaccines
  • Therapeutic Cancer Vaccines

8: Market By Application

  • Global Market For Cancer Vaccines By Application In Various Cancers
  • Prostate Cancer
  • Liver Cancer
  • Cervical Cancer Vaccines
  • Other Vaccines For Cancer

9: Patent Analysis

  • Patents By Year
  • Patents By Type/Category
  • Patents By Company
  • Patents By Country
  • Patents By Assignee Type

10: Current Situation

  • Factors Affecting Cancer Vaccines
  • Challenges In Cancer Vaccine Market

11: Company Profiles

  • Adamis Pharmaceuticals Corp.
  • Aduro Biotech Inc.
  • Advantagene Inc.
  • Advaxis Inc.
  • Alphavax Inc.
  • Altor Bioscience Corp.
  • Antigen Express Inc.
  • Bavarian Nordic A/S
  • Bellicum Pharmaceuticals
  • Biovest International Inc.
  • Cascadian Therapeutics Inc.
  • Celldex Therapeutics
  • Curevac AG
  • Dendreon Corp.
  • EMD Serono
  • Galena Biopharma Inc.
  • Genexine Inc.
  • Glaxosmithkline
  • Globeimmune Inc.
  • Gradalis
  • Heat Biologics Inc.
  • Immune Cell Therapy Inc. (Ict)
  • Immunicum AB
  • Immunovative Therapies Ltd.
  • Inovio Pharmaceuticals
  • ISA Pharmaceuticals B.V.
  • Gemvax & Kael Co. Ltd.
  • Merck & Co.
  • Newlink Genetics Corp.
  • Novarx Corp.
  • Oncovir Inc.
  • Oxford Biomedica Plc
  • Sotio AS
  • Ubivac Llc
  • Vical Inc.
  • Vaccinogen Inc.
  • Vaxon Biotech

12: Abbreviations

List Of Tables

Summary Table : Global Market For Cancer Vaccines By Region, Through 2021
Table 1 : History Of Cancer And Its Management
Table 2 : Regulatory Approvals Of Cancer Vaccines, June 2006 To Oct. 2015
Table 3 : Product Recalls, December 2013
Table 4 : Significant Orphan Drug Designations Approved, Jan. 2012 To June 2016
Table 5 : Clinical Trials On Prostate Cancer Vaccines, As Of June 2016
Table 6 : Significant Prostate Cancer Vaccines In Development, As Of June 2016
Table 7 : Clinical Trials On Breast Cancer Vaccines, As Of June 2016
Table 8 : Significant Breast Cancer Vaccines In Development, As Of June 2016
Table 9 : Clinical Trials On Cervical Cancer Vaccines, As Of June 2016
Table 10 : Significant Cervical Cancer Vaccines In Development, As Of June 2016
Table 11 : Clinical Trials On Liver Cancer Vaccines, As Of June 2016
Table 12 : Significant Liver Cancer Vaccines In Development, As Of June 2016
Table 13 : Clinical Trials On Lung Cancer Vaccines, As Of June 2016
Table 14 : Significant Vaccines In Development For Lung Cancer, As Of June 2016
Table 15 : Clinical Trials On Stomach Cancer Vaccines, As Of June 2016
Table 16 : Significant Stomach Cancer Vaccines In Development, As Of June 2016
Table 17 : Clinical Trials On Colorectal Cancer Vaccines, As Of June 2016
Table 18 : Significant Colorectal Cancer Vaccines In Development, As Of June 2016
Table 19 : Clinical Trials On Esophageal Cancer Vaccines, As Of June 2016
Table 20 : Significant Esophageal Cancer Vaccines In Development, As Of June 2016
Table 21 : Global Market For Cancer Vaccines By Type, Through 2021
Table 22 : Market Share Of Cancer Vaccines By Type, 2015
Table 23 : Global Market For Cancer Vaccines By Region, Through 2021
Table 24 : Global Market For Therapeutic Cancer Vaccines By Region, Through 2021
Table 25 : Market Shares Of Therapeutic Vaccines By Region, 2015
Table 26 : Global Market For Prophylactic Cancer Vaccines By Region, Through 2021
Table 27 : Prophylactic Vaccine Market Shares By Region, 2015
Table 28 : Leading Manufacturers/Suppliers Of Prophylactic Cancer Vaccines, 2015
Table 29 : Manufacturer/Supplier Market Shares Of Prophylactic Cancer Vaccines, 2015
Table 30 : Leading Manufacturers/Suppliers Of Therapeutic Cancer Vaccines, 2015
Table 31 : Manufacturer/Supplier Market Shares Of Therapeutic Cancer Vaccines, 2015
Table 32 : Global Market For Cancer Vaccines By Type Of Cancer, Through 2021
Table 33 : Cancer Vaccine Market Shares By Type Of Cancer, 2015
Table 34 : Global Market For Prostate Cancer Vaccines By Region, Through 2021
Table 35 : Global Market For Liver Cancer Vaccines By Region, Through 2021
Table 36 : Global Market For Cervical Cancer Vaccines By Region, Through 2021
Table 37 : Global Market For Other Cancer Vaccines By Region, Through 2021
Table 38 : U.S. Patents By Year, 2012 To June 2016
Table 39 : U.S. Patents By Category, 2012 To June 2016
Table 40 : U.S. Patents By Company, 2012 To June 2016
Table 41 : U.S. Patents By Country, 2012 To June 2016
Table 42 : U.S. Patent Shares By Country, 2012 To June 2016
Table 43 : U.S. Patents By Assignee Type, Jan. 2012 To June 2016

List Of Figures

Summary Figure : Global Market For Cancer Vaccines By Region, 2014-2021
Figure 1 : Global Market For Cancer Vaccines By Type, 2014-2021
Figure 2 : Market Share Of Cancer Vaccines By Type, 2015
Figure 3 : Global Market For Cancer Vaccines By Region, 2014-2021
Figure 4 : Global Market For Therapeutic Cancer Vaccines By Region, 2014-2021
Figure 5 : Market Shares Of Therapeutic Vaccines By Region, 2015
Figure 6 : Global Market For Prophylactic Cancer Vaccines By Region, 2014-2021
Figure 7 : Prophylactic Vaccine Market Shares By Region, 2015
Figure 8 : Manufacturer/Supplier Market Shares Of Prophylactic Cancer Vaccines, 2015
Figure 9 : Manufacturer/Supplier Market Shares Of Therapeutic Cancer Vaccines, 2015
Figure 10 : Global Market For Cancer Vaccines By Type Of Cancer, 2014-2021
Figure 11 : Cancer Vaccine Market Shares By Type Of Cancer, 2015
Figure 12 : Global Market For Prostate Cancer Vaccines By Region, 2014-2021
Figure 13 : Global Market For Liver Cancer Vaccines By Region, 2014-2021
Figure 14 : Global Market For Cervical Cancer Vaccines By Region, 2014-2021
Figure 15 : Global Market For Other Cancer Vaccines By Region, 2014-2021
Figure 16 : U.S. Patents By Year, 2012 To June 2016
Figure 17 : U.S. Patents By Category, 2012 To June 2016
Figure 18 : U.S. Patent Shares By Country, 2012 To June 2016
Figure 19 : U.S. Patents By Assignee Type, Jan. 2012 To June 2016

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6

FEATURED COMPANIES

  • Aduro Biotech Inc.
  • Antigen Express Inc.
  • Dendreon Corp.
  • Glaxosmithkline
  • Inovio Pharmaceuticals
  • Oncovir Inc.
  • MORE

Analysts’ Credentials

The study has been carried out by a team of professionals in the biotechnology industry. The project manager for this report is Shalini S. Dewan, who holds a master’s degree in pharmaceutical chemistry and has more than 14 years of industry experience. Shalini was awarded a Gold Medal by the Prime Minister of India for her work and she has worked with top companies in India and the U.S.

The lead consultant on this project was Dr. Kapil A. Setia, who holds a doctoral degree in the life sciences. She has a number of research publications to her credit, including her thesis, which received an award for excellence.

Note: Product cover images may vary from those shown
5 of 6
  • Adamis Pharmaceuticals Corp.
  • Aduro Biotech Inc.
  • Advantagene Inc.
  • Advaxis Inc.
  • Alphavax Inc.
  • Altor Bioscience Corp.
  • Antigen Express Inc.
  • Bavarian Nordic A/S
  • Bellicum Pharmaceuticals
  • Biovest International Inc.
  • Cascadian Therapeutics Inc.
  • Celldex Therapeutics
  • Curevac AG
  • Dendreon Corp.
  • EMD Serono
  • Galena Biopharma Inc.
  • Genexine Inc.
  • Glaxosmithkline
  • Globeimmune Inc.
  • Gradalis
  • Heat Biologics Inc.
  • Immune Cell Therapy Inc. (Ict)
  • Immunicum AB
  • Immunovative Therapies Ltd.
  • Inovio Pharmaceuticals
  • ISA Pharmaceuticals B.V.
  • Gemvax & Kael Co. Ltd.
  • Merck & Co.
  • Newlink Genetics Corp.
  • Novarx Corp.
  • Oncovir Inc.
  • Oxford Biomedica Plc
  • Sotio AS
  • Ubivac Llc
  • Vical Inc.
  • Vaccinogen Inc.
  • Vaxon Biotech
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll